#KO
### π’ μ½”λ‚μ§„μ •(μ„Έν‹°λ¦¬μ§„μ—Όμ‚°μ—Ό)(μμ¶λ…:μ•λ¦¬μ½”μ—Όμ‚°μ„Έν‹°λ¦¬μ§„μ •,λ³΄νμ„Έν‹°λ¦¬μ§„λ‚μ •,μμ΄μ΅°μ„ΈνΈμ •) - ν¨λ¥ λ° ν¨κ³Ό
* μ΄ μ•½μ€ κ³„μ μ„± λ° λ‹¤λ…„μ„± μ•λ λ¥΄κΈ°μ„± λΉ„μ—Ό, μ•λ λ¥΄κΈ°μ„± κ²°λ§‰μ—Ό, λ§μ„± νΉλ°μ„± λ‘λ“λ¬κΈ°, ν”Όλ¶€κ°€λ ¤μ›€μ¦κ³ΌΒ ν•μ΄λ“λ΅μ½”ν‹°μ† μ™Έμ©μ μ™€ λ³‘μ©μ— μν• μµμ§„, ν”Όλ¶€μ—Όμ— μ‚¬μ©ν•©λ‹λ‹¤.

### π•’ μ½”λ‚μ§„μ •(μ„Έν‹°λ¦¬μ§„μ—Όμ‚°μ—Ό)(μμ¶λ…:μ•λ¦¬μ½”μ—Όμ‚°μ„Έν‹°λ¦¬μ§„μ •,λ³΄νμ„Έν‹°λ¦¬μ§„λ‚μ •,μμ΄μ΅°μ„ΈνΈμ •) - μ©λ²• λ° μ©λ‰
* μ„±μΈ λ° 6μ„Έ μ΄μƒμ μ†μ•„λ” 1μΌ 1ν 1μ •(10 mg)μ„ μ·¨μΉ¨ μ „μ— λ³µμ©ν•κ³ , μ΄μƒλ°μ‘μ— λ―Όκ°ν• ν™μμ κ²½μ°λ”Β 1/2μ •(5 mg)μ”©μ„ μ•„μΉ¨, μ €λ…μ— λ¶„ν•  λ³µμ©ν•©λ‹λ‹¤.μ—°λ Ή, μ¦μƒμ— λ”°λΌ μ μ ν μ¦κ°ν•©λ‹λ‹¤.μ‹ μ¥μ•  ν™μμ ν¬μ—¬ κ°„κ²©μ€ ν™μμ μ‹ κΈ°λ¥μ— λ”°λΌ μ΅°μ λμ–΄μ•Ό ν•κ³ , μ‹ μ¥μ• λ¥Ό κ°€μ§„ μ†μ•„ ν™μλ” ν™μμ μ‹  μ²­μ†μ¨κ³Ό μ²΄μ¤‘μ„ κ³ λ ¤ν•μ—¬ κ°λ³„μ μΌλ΅ μ©λ‰μ„ μ΅°μ ν•΄μ•Ό ν•λ―€λ΅ μμ„Έν• μ‚¬ν•­μ€ ν—κ°€μ‚¬ν•­μ„ μ°Έκ³ ν•μ‹­μ‹μ¤.

### β οΈ μ½”λ‚μ§„μ •(μ„Έν‹°λ¦¬μ§„μ—Όμ‚°μ—Ό)(μμ¶λ…:μ•λ¦¬μ½”μ—Όμ‚°μ„Έν‹°λ¦¬μ§„μ •,λ³΄νμ„Έν‹°λ¦¬μ§„λ‚μ •,μμ΄μ΅°μ„ΈνΈμ •) - μ£Όμμ‚¬ν•­
* μ •λ³΄ μ—†μ
* μ΄ μ•½ λ°Β νλ“λ΅μ‹μ§„ λλ” ν”ΌνλΌμ§„ μ λ„μ²΄μ— κ³Όλ―Όμ¦ ν™μ, μ‹ λ¶€μ „ ν™μ(ν¬λ μ•„ν‹°λ‹ μ²­μ†μ¨ μ΄ μ•½μ„ λ³µμ©ν•κΈ° μ „μ— μ‹ μ¥μ• , κ°„μ¥μ•  ν™μ, λ…ΈμΈ,Β κ°„μ§ λ° λ°μ‘ μ„ν—μ„±μ΄ μλ” ν™μ,Β μ†λ³€κ³ μ„μ μ„ ν–‰μ”μΈ(μ²™μ λ³‘λ³€, μ „λ¦½μ„  λΉ„λ€μ¦)μ΄ μλ” ν™μλ” μμ‚¬ λλ” μ•½μ‚¬μ™€ μƒμν•μ‹­μ‹μ¤.

# EN
### π’ μ½”λ‚μ§„μ •(μ„Έν‹°λ¦¬μ§„μ—Όμ‚°μ—Ό)(μμ¶λ…:μ•λ¦¬μ½”μ—Όμ‚°μ„Έν‹°λ¦¬μ§„μ •,λ³΄νμ„Έν‹°λ¦¬μ§„λ‚μ •,μμ΄μ΅°μ„ΈνΈμ •) - Efficacy and Effects
* This medicine is used for seasonal and perennial allergic rhinitis, allergic conjunctivitis, chronic idiopathic urticaria, pruritus, and in combination with topical hydrocortisone for eczema and dermatitis.

### π•’ μ½”λ‚μ§„μ •(μ„Έν‹°λ¦¬μ§„μ—Όμ‚°μ—Ό)(μμ¶λ…:μ•λ¦¬μ½”μ—Όμ‚°μ„Έν‹°λ¦¬μ§„μ •,λ³΄νμ„Έν‹°λ¦¬μ§„λ‚μ •,μμ΄μ΅°μ„ΈνΈμ •) - Dosage and Administration
* Adults and children 6 years of age and older should take 1 tablet (10 mg) once daily at bedtime. For patients sensitive to adverse reactions, 1/2 tablet (5 mg) should be taken twice daily, in the morning and evening. The dosage may be adjusted appropriately depending on age and symptoms. The dosing interval for patients with renal impairment should be adjusted according to the patient's renal function, and pediatric patients with renal impairment require individualized dosage adjustment considering the patient's renal clearance and body weight, so please refer to the product monograph for detailed information.

### β οΈ μ½”λ‚μ§„μ •(μ„Έν‹°λ¦¬μ§„μ—Όμ‚°μ—Ό)(μμ¶λ…:μ•λ¦¬μ½”μ—Όμ‚°μ„Έν‹°λ¦¬μ§„μ •,λ³΄νμ„Έν‹°λ¦¬μ§„λ‚μ •,μμ΄μ΅°μ„ΈνΈμ •) - Precautions
* No information
* Patients with hypersensitivity to this medicine, hydroxyzine, or piperazine derivatives, and patients with renal failure (creatinine clearance Before taking this medicine, patients with renal impairment, hepatic impairment, elderly individuals, patients with epilepsy or a risk of seizures, and patients with predisposing factors for urinary retention (e.g., spinal cord lesion, benign prostatic hyperplasia) should consult a doctor or pharmacist.

# CN
### π’ μ½”λ‚μ§„μ •(μ„Έν‹°λ¦¬μ§„μ—Όμ‚°μ—Ό)(μμ¶λ…:μ•λ¦¬μ½”μ—Όμ‚°μ„Έν‹°λ¦¬μ§„μ •,λ³΄νμ„Έν‹°λ¦¬μ§„λ‚μ •,μμ΄μ΅°μ„ΈνΈμ •) - εζ•δΈδ½η”¨
* ζ¬θ―η”¨δΊε­£θ‚ζ€§εεΈΈεΉ΄ζ€§θΏ‡ζ•ζ€§ιΌ»η‚γ€θΏ‡ζ•ζ€§η»“θ†η‚γ€ζ…Άζ€§η‰Ήε‘ζ€§θ¨ιΊ»η–Ήγ€η®θ‚¤η™η—’η—‡οΌδ»¥εδΈζ°Άε–ε―η„ζΎε¤–η”¨ε¶ε‰‚θ”εη”¨δΊζΉΏη–Ήε’η®η‚γ€‚

### π•’ μ½”λ‚μ§„μ •(μ„Έν‹°λ¦¬μ§„μ—Όμ‚°μ—Ό)(μμ¶λ…:μ•λ¦¬μ½”μ—Όμ‚°μ„Έν‹°λ¦¬μ§„μ •,λ³΄νμ„Έν‹°λ¦¬μ§„λ‚μ •,μμ΄μ΅°μ„ΈνΈμ •) - η”¨ζ³•η”¨ι‡
* ζδΊΊε6ε²δ»¥δΈε„Ώη«¥ζ―ζ—¥δΈ€ζ¬΅οΌη΅ε‰ζη”¨1η‰‡οΌ10 mgοΌ‰γ€‚ε―ΉδΊε―ΉδΈθ‰―εεΊ”ζ•ζ„η„ζ‚£θ€…οΌε―ε†ζ—©ζ™δΈ¤ζ¬΅ζη”¨1/2η‰‡οΌ5 mgοΌ‰γ€‚ε‰‚ι‡ε―ζ Ήζ®εΉ΄ιΎ„ε’η—‡η¶ι€‚ε½“εΆε‡γ€‚θ‚Ύεθƒ½δΈε…¨ζ‚£θ€…η„η»™θ―ι—΄ι”εΊ”ζ Ήζ®ζ‚£θ€…η„θ‚Ύεθƒ½θΏ›θ΅θ°ƒζ•΄οΌε―ΉδΊζ‚£ζ‰θ‚Ύεθƒ½δΈε…¨η„ε„Ώη«¥ζ‚£θ€…οΌι€ζ Ήζ®ζ‚£θ€…η„θ‚ΎζΈ…ι™¤η‡ε’δ½“ι‡θΏ›θ΅δΈδ½“ε–ε‰‚ι‡θ°ƒζ•΄οΌθ―¦ζƒ…θ―·ε‚ι…θ―΄ζδΉ¦γ€‚

### β οΈ μ½”λ‚μ§„μ •(μ„Έν‹°λ¦¬μ§„μ—Όμ‚°μ—Ό)(μμ¶λ…:μ•λ¦¬μ½”μ—Όμ‚°μ„Έν‹°λ¦¬μ§„μ •,λ³΄νμ„Έν‹°λ¦¬μ§„λ‚μ •,μμ΄μ΅°μ„ΈνΈμ •) - ζ³¨ζ„δΊ‹ι΅Ή
* ζ— δΏ΅ζ―
* ε―Ήζ¬θ―γ€ηΎε—ζ–ε“ε—θ΅η”η‰©θΏ‡ζ•η„ζ‚£θ€…οΌθ‚Ύθ΅°η«­ζ‚£θ€…οΌθ‚ι…ζΈ…ι™¤η‡ ζη”¨ζ¬θ―ε‰οΌθ‚Ύεθƒ½δΈε…¨ζ‚£θ€…γ€θ‚εθƒ½δΈε…¨ζ‚£θ€…γ€θ€εΉ΄δΊΊγ€η™«η—«εζ‰η™«η—«ε‘δ½ι£ι™©η„ζ‚£θ€…γ€δ»¥εζ‰ε°Ώζ½΄η•™ε…ε†³ζ΅δ»¶οΌε¦‚θ„ι«“η—…εγ€ε‰ε—θ…Ίθ‚¥ε¤§οΌ‰η„ζ‚£θ€…οΌθ―·ε’¨θ―Άε»η”ζ–θ―εΈγ€‚

# JP
### π’ μ½”λ‚μ§„μ •(μ„Έν‹°λ¦¬μ§„μ—Όμ‚°μ—Ό)(μμ¶λ…:μ•λ¦¬μ½”μ—Όμ‚°μ„Έν‹°λ¦¬μ§„μ •,λ³΄νμ„Έν‹°λ¦¬μ§„λ‚μ •,μμ΄μ΅°μ„ΈνΈμ •) - εΉθƒ½εγ³εΉζ
* ζ¬ε‰¤γ―γ€ε­£η―€ζ€§εγ³ι€εΉ΄ζ€§γ‚Άγƒ¬γƒ«γ‚®γƒΌζ€§ιΌ»η‚γ€γ‚Άγƒ¬γƒ«γ‚®γƒΌζ€§ηµθ†η‚γ€ζ…Άζ€§η‰Ήη™Ίζ€§θ•ιΊ»η–Ήγ€η®θ†γγ†η—’η—‡γ€δΈ¦γ³γ«γƒ’γƒ‰γƒ­γ‚³γƒ«γƒγ‚Ύγƒ³ε¤–η”¨θ–¬γ¨γ®δ½µη”¨γ«γ‚γ‚‹ζΉΏη–Ήγ€η®θ†η‚γ«η”¨γ„γ‚‰γ‚γΎγ™γ€‚

### π•’ μ½”λ‚μ§„μ •(μ„Έν‹°λ¦¬μ§„μ—Όμ‚°μ—Ό)(μμ¶λ…:μ•λ¦¬μ½”μ—Όμ‚°μ„Έν‹°λ¦¬μ§„μ •,λ³΄νμ„Έν‹°λ¦¬μ§„λ‚μ •,μμ΄μ΅°μ„ΈνΈμ •) - η”¨ζ³•εγ³η”¨ι‡
* ζδΊΊεγ³6ζ­³δ»¥δΈγ®ε°ε…γ―γ€1ζ—¥1ε›1ι οΌ10 mgοΌ‰γ‚’ε°±ε―ε‰γ«ζη”¨γ—γ€ε‰―δ½η”¨γ«ζ•ζ„γζ‚£θ€…γ®ε ΄εγ―γ€1/2ι οΌ5 mgοΌ‰γ‚’ζε¤•γ«ε†ε‰²γ—γ¦ζη”¨γ—γΎγ™γ€‚εΉ΄ι½Άγ€η—‡η¶γ«εΏγγ¦ι©ε®εΆ—ζΈ›γ—γΎγ™γ€‚θ…ζ©θƒ½ιε®³ζ‚£θ€…γΈγ®ζ•δΈι–“ι”γ―γ€ζ‚£θ€…γ®θ…ζ©θƒ½γ«εΏγγ¦θΏζ•΄γ™γ‚‹εΏ…θ¦γγ‚γ‚γ€θ…ζ©θƒ½ιε®³γ‚’ζ‰γ™γ‚‹ε°ε…ζ‚£θ€…γ―γ€ζ‚£θ€…γ®θ…γ‚―γƒγ‚Άγƒ©γƒ³γ‚Ήγ¨δ½“ι‡γ‚’θ€ƒζ…®γ—γ¦ε€‹ε¥γ«η”¨ι‡γ‚’θΏζ•΄γ™γ‚‹εΏ…θ¦γγ‚γ‚‹γγ‚γ€θ©³η΄°γ«γ¤γ„γ¦γ―ζ·»δ»ζ–‡ζ›Έγ‚’ε‚η…§γ—γ¦γγ γ•γ„γ€‚

### β οΈ μ½”λ‚μ§„μ •(μ„Έν‹°λ¦¬μ§„μ—Όμ‚°μ—Ό)(μμ¶λ…:μ•λ¦¬μ½”μ—Όμ‚°μ„Έν‹°λ¦¬μ§„μ •,λ³΄νμ„Έν‹°λ¦¬μ§„λ‚μ •,μμ΄μ΅°μ„ΈνΈμ •) - ζ³¨ζ„δΊ‹ι …
* ζƒ…ε ±γγ—
* ζ¬ε‰¤εγ³γƒ’γƒ‰γƒ­γ‚­γ‚·γ‚Έγƒ³εγ―γƒ”γƒγƒ©γ‚Έγƒ³θε°δ½“γ«ε―Ύγ—ιζ•η—‡γ®ζ‚£θ€…γ€θ…δΈε…¨ζ‚£θ€…οΌγ‚―γƒ¬γ‚Άγƒγƒ‹γƒ³γ‚―γƒγ‚Άγƒ©γƒ³γ‚Ή ζ¬ε‰¤γ‚’ζη”¨γ™γ‚‹ε‰γ«γ€θ…ζ©θƒ½ιε®³γ€θ‚ζ©θƒ½ιε®³ζ‚£θ€…γ€ι«ι½Άθ€…γ€γ¦γ‚“γ‹γ‚“εγ³η™Ίδ½γ®γƒγ‚Ήγ‚―γγ‚γ‚‹ζ‚£θ€…γ€ε°Ώι–‰γ®ε…θ΅θ¦ε› οΌθ„ι«„η—…ε¤‰γ€ε‰η«‹θ…Ίθ‚¥ε¤§η—‡οΌ‰γγ‚γ‚‹ζ‚£θ€…γ―γ€ε»εΈ«εγ―θ–¬ε‰¤εΈ«γ«η›Έθ«‡γ—γ¦γγ γ•γ„γ€‚